author-photo

Minoo Niknian

Bayer Corporation

6

Papers

174

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Original research article Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen ☆

2010 Contraception
Show All
- Source
- Cite
- Save
Citations (0)
A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts investigator ratings and subject self-assessment.

2009 Journal of Drugs in Dermatology
Show All
- Source
- Cite
- Save
Citations (16)
A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.

2008 Cutis
Show All
- Source
- Cite
- Save
Citations (29)
Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial

2008 Contraception
Show All
- Source
- Cite
- Save
Citations (74)
Determining Clinically Meaningful Benefit in the Treatment of Premenstrual Dysphoric Disorder

2006 Obstetrics & Gynecology
Show All
- Source
- Cite
- Save
Citations (1)